CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
The goal of this clinical trial is to learn if OPB-101 is safe in platinum resistant ovarian cancer participants and also to find t...
Phase 1
Houston, Texas, United States and 3 other locations
a Phase 1 study to assess safety, tolerability, pharmacokinetics, immunogenicity, and antitumor activity of ARR-002 in advanced or metastatic ovarian...
Phase 1
Houston, Texas, United States and 5 other locations
A research study evaluating a new oncolytic virus, THEO-260, in patients with advanced ovarian cancer. The trial will investigate d...
Phase 1
Houston, Texas, United States
To develop a shared decision-making (SDM) tool to help Spanish-speaking patients make decisions about their maintenance therapy
Houston, Texas, United States
bevacizumab in women diagnosed with platinum-resistant/refractory ovarian cancer (includes fallopian tube cancer and prima...
Phase 3
Houston, Texas, United States and 32 other locations
To learn if adding lurbinectedin to the combination of paclitaxel and bevacizumab can help to control advanced cancer....
Phase 1
Houston, Texas, United States
Ovarian cancer is a lethal disease with an estimated 310,000 new cases and 200,000 deaths experienced worldwide in 2020. The purpos ...
Phase 2
The Woodlands, Texas, United States and 83 other locations
the safety and efficacy of avutometinib (VS-6766) monotherapy and in combination with defactinib in subjects with recurrent Low-Grade Serous Ovarian...
Phase 2
The Woodlands, Texas, United States and 46 other locations
combination of NMS-03305293 and topotecan in patients with recurrent ovarian cancer, with dose-limiting toxicity (DLT) escalation. ...
Phase 1
Houston, Texas, United States and 4 other locations
efficacy with the combination of a next generation anti-CTLA-4 antibody, ONC-392, and anti-PD-1 antibody, pembrolizumab, in platinum resistant ovarian...
Phase 2
The Woodlands, Texas, United States and 20 other locations
Clinical trials
Research sites
Resources
Legal